Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik J Dasbach

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 19, 2003
The use of claims databases in pharmacoeconomic studiesErik J Dasbach
Pharmacoeconomics|May 1, 2017
Verification of Decision-Analytic Models for Health Economic Evaluations: An OverviewErik J Dasbach, Elamin H Elbasha
Vaccine|August 18, 2010
Impact of vaccinating boys and men against HPV in the United StatesElamin H Elbasha, Erik J Dasbach
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Assessment of the cost-effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission modelErik J Dasbach, Nathalie Largeron, Elamin H Elbasha
Surgical Infections|September 9, 2004
The burden of appendicitis-related hospitalizations in the United States in 1997Glenn M Davies, Erik J Dasbach, Steven Teutsch
The Lancet. Infectious Diseases|July 25, 2009
Economics of stockpiling for an influenza pandemicPraveen Dhankhar, Erik J Dasbach, Elamin H Elbasha
Expert Review of Vaccines|September 5, 2008
Structural differences among cost-effectiveness models of human papillomavirus vaccinesRalph P Insinga, Erik J Dasbach, Elamin H Elbasha
BMC Infectious Diseases|July 31, 2009
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission modelRalph P Insinga, Erik J Dasbach, Elamin H Elbasha
Bulletin of Mathematical Biology|October 9, 2008
A multi-type HPV transmission modelElamin H Elbasha, Erik J Dasbach, Ralph P Insinga
Pharmacoeconomics|November 10, 2005
Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literatureRalph P Insinga, Erik J Dasbach, Elamin H Elbasha
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 19, 2003
The use of claims databases in pharmacoeconomic studiesErik J Dasbach
Pharmacoeconomics|May 1, 2017
Verification of Decision-Analytic Models for Health Economic Evaluations: An OverviewErik J Dasbach, Elamin H Elbasha
Vaccine|August 18, 2010
Impact of vaccinating boys and men against HPV in the United StatesElamin H Elbasha, Erik J Dasbach
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Assessment of the cost-effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission modelErik J Dasbach, Nathalie Largeron, Elamin H Elbasha
Surgical Infections|September 9, 2004
The burden of appendicitis-related hospitalizations in the United States in 1997Glenn M Davies, Erik J Dasbach, Steven Teutsch
The Lancet. Infectious Diseases|July 25, 2009
Economics of stockpiling for an influenza pandemicPraveen Dhankhar, Erik J Dasbach, Elamin H Elbasha
Expert Review of Vaccines|September 5, 2008
Structural differences among cost-effectiveness models of human papillomavirus vaccinesRalph P Insinga, Erik J Dasbach, Elamin H Elbasha
BMC Infectious Diseases|July 31, 2009
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission modelRalph P Insinga, Erik J Dasbach, Elamin H Elbasha
Bulletin of Mathematical Biology|October 9, 2008
A multi-type HPV transmission modelElamin H Elbasha, Erik J Dasbach, Ralph P Insinga
Pharmacoeconomics|November 10, 2005
Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literatureRalph P Insinga, Erik J Dasbach, Elamin H Elbasha
Pageof 4